
FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe …
FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted Read More